Investigational MERS vaccine receives approval for Phase I trial in South Korea
by Press Release from Outbreak News Today on (#32SDB)
GeneOne Life Science, Inc. announces that it has received approval from the South Korean Ministry of Food and Drug Safety (KMFDS) for an Investigational New Drug application for a Phase I/IIa study of its investigational vaccine, GLS-5300, against the Middle East Respiratory Syndrome coronavirus (MERS-CoV). The study in Korea represents the second clinical trial for ["]
The post Investigational MERS vaccine receives approval for Phase I trial in South Korea appeared first on Outbreak News Today.